Clinical Trial Update: Impact of Antenatal Corticosteroid Therapy on Postnatal Surfactant Use in Preterm Infants

View source ↗

Summary

This completed clinical trial evaluates whether antenatal corticosteroid therapy affects the amount of postnatal surfactant required in preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyaline Membrane Disease

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• betamethasone (betamethasone)

Snippet

Sponsor: Hôpital NOVO | Conditions: Hyaline Membrane Disease (HMD) | Status: COMPLETED